Cargando…
CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
CD96 is a promising candidate for immunotherapy. However, its role and importance in glioma remains unknown. We thus aimed to genetically and clinically characterize CD96 expression in gliomas. For this, we extracted RNA-seq data of 699 glioma samples from the TCGA dataset and validated these findin...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330044/ https://www.ncbi.nlm.nih.gov/pubmed/32612110 http://dx.doi.org/10.1038/s41598-020-66806-z |